REG - OptiBiotix Health - Holding(s) in Company <Origin Href="QuoteRef">OPTIO.L</Origin>
For best results when printing this announcement, please click on the link
below:
http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20151007:nRSG5328Ba
RNS Number : 5328B
OptiBiotix Health PLC
07 October 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Optibiotix Health plc
Optibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii Finance Yorkshire Seedcorn Fund (FYSCF)
4. Full name of shareholder(s)(if different from 3.): iv
5. Date of the transaction and date on which the threshold is crossed or reached: v 25 September 2015
6. Date on which issuer notified: 7 October 2015
7. Threshold(s) that is/are crossed orreached: vi, vii 18%
8. Notified details:
A: Voting rights attached to sharesviii, ix
Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
if possible using transaction
the ISIN CODE
Number Number Number Number of voting % of voting rightsx
of of of shares rights
Shares Voting
Rights
Direct Directxi Indirectxii Direct Indirect
GB00BP0RTP38 13,998,238 13,998,238 12,598,238 12,598,238 nil 17.120 Nil
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument datexiii Conversion rights that may be rights
Periodxiv acquired if the
instrument is
exercised/ converted.
None
C: Financial Instruments with similar economic effect to Qualifying Financial Instrumentsxv, xvi
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting % of voting rightsxix, xx
instrument price datexvii Conversion rights instrument
periodxviii refers to
None Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
12,598,238 17.12%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Enterprise Ventures Limited
15. Contact telephone number: 01772 270 570
This information is provided by RNS
The company news service from the London Stock ExchangeRecent news on OptiBiotix Health
See all newsREG - OptiBiotix Health - WellBiome® clinical trial on surgical outcomes
AnnouncementREG - OptiBiotix Health - Statement: SkinBioTherapeutics Announcement
AnnouncementREG - OptiBiotix Health - Large Order and Record Early Orders for 2026
AnnouncementRCS - OptiBiotix Health - New Investor Website
AnnouncementREG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
Announcement